Pacira BioSciences, Inc. PCRX Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s accrued liabilities, current?
- Pacira BioSciences, Inc. (PCRX) reported accrued liabilities, current of $84.96M in Q1 2026.
- How has Pacira BioSciences, Inc.'s accrued liabilities, current changed year-over-year?
- Pacira BioSciences, Inc.'s accrued liabilities, current increased by 6.1% year-over-year, from $80.07M to $84.96M.
- What is the long-term trend for Pacira BioSciences, Inc.'s accrued liabilities, current?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s accrued liabilities, current has grown at a 6.1% compound annual growth rate (CAGR), from $70.97M to $95.6M.